Applied Clinical Trials
Applied Clinical Trials-05-01-2019
Volume: 28
Issue: 5
Applied Clinical Trials-04-01-2019
Volume: 28
Issue: 4
Applied Clinical Trials-03-01-2019
Volume: 28
Issue: 3
Applied Clinical Trials-01-01-2019
Volume: 28
Issue: 1
Applied Clinical Trials-12-01-2018
Volume: 27
Issue: 12
Applied Clinical Trials-11-01-2018
Volume: 27
Issue: 11
Applied Clinical Trials-10-01-2018
Volume: 27
Issue: 10
Applied Clinical Trials-09-01-2018
Volume: 27
Issue: 9
Applied Clinical Trials-07-01-2018
Volume: 27
Issue: 7
Applied Clinical Trials-06-01-2018
Volume: 27
Issue: 6
Applied Clinical Trials-05-01-2018
Volume: 27
Issue: 5
Applied Clinical Trials-04-01-2018
Volume: 27
Issue: 4
Applied Clinical Trials-03-01-2018
Volume: 27
Issue: 3
Applied Clinical Trials-02-01-2018
Volume: 27
Issue: 2
Applied Clinical Trials-12-01-2017
Volume: 26
Issue: 12
Applied Clinical Trials-10-01-2017
Volume: 26
Issue: 10
Applied Clinical Trials-08-01-2017
Volume: 26
Issue: 8
Applied Clinical Trials-06-01-2017
Volume: 26
Issue: 6
Applied Clinical Trials-04-01-2017
Volume: 26
Issue: 4
Applied Clinical Trials-02-01-2017
Volume: 26
Issue: 2
Applied Clinical Trials-12-01-2016
Volume: 25
Issue: 12
Applied Clinical Trials-10-01-2016
Volume: 25
Issue: 10
Applied Clinical Trials-08-01-2016
Volume: 25
Issue: 8
Applied Clinical Trials-06-01-2016
Volume: 25
Issue: 6
Applied Clinical Trials-04-01-2016
Volume: 25
Issue: 4
Applied Clinical Trials Digital Edition-04-01-2016
Volume: 25
Issue: 4
Applied Clinical Trials-02-01-2016
Volume: 25
Issue: 2
Applied Clinical Trials Digital Edition-02-01-2016
Volume: 25
Issue: 2
Applied Clinical Trials-12-01-2015
Volume: 24
Issue: 12
Applied Clinical Trials Digital Edition-12-01-2015
Volume: 24
Issue: 12
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
The Value of Pragmatic Randomized Clinical Trials: Strategic Approaches for Real-World Impact
3
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
4
Driving Collaboration Across Functions to Streamline Drug Development
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
